Despite therapeutic advances, the prognosis of pulmonary hypertension remains poor which likely reflects in part delayed detection of the disease and scarcity of disease modifying therapies currently available. The former is important especially amongst health care providers given the myriad of conditions that can result in pulmonary hypertension, including chronic liver disease, left heart disease, and connective tissue disease. Early recognition of pulmonary hypertension and recognizing the in...